PCR For Respiratory Infection Diagnostic Market Consolidations Strategies Adopted by Use of PCR Testing for Various Respiratory Infection Diagnostics
According to our new research study on “PCR for respiratory infection diagnostics market” Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product Type, Infection Type, End User,” the market is expected to reach US$ 8279.32 million by 2028 from US$ 4,146.02 million in 2021; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth.
Polymerase chain reaction (PCR) is used for accurate point of care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is widely preferred in inpatient and outpatient settings that help enhance the growth of the market in recent years.
Download sample PDF Copy of study at: https://www.theinsightpartners.com/sample/TIPRE00023326/
Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Abbott; F. Hoffmann-La Roche Ltd; Hologic, Inc.; Seegene Inc.; AusDiagnostics; BD; bioMérieux SA; and Qiagen are among the leading companies operating in the PCR for respiratory infection diagnostics market.
The growth of the PCR for respiratory infection diagnostics market is attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth.
Market Consolidations Strategies Adopted by Use of PCR Testing for Various Respiratory Infection Diagnostics
PCR testing is the gold standard for detecting respiratory infectious diseases, including SARS-CoV-2. Also, the growing developments in PCR are not limited to the COVID-19 testing. The continuous technological developments have allowed researchers to develop advanced PCR techniques at a reduced cost and limit their complexities. It is expected that PCR testing will enhance its capabilities for molecular diagnostics and strengthen its role in the future with the ongoing developments of technologies such as microfluidics and next-generation sequencing. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals, for identifying influenza virus infection that causes respiratory outbreaks.
Moreover, acute and chronic respiratory infections are among the leading causes of morbidities in the developed and developing countries globally. It is estimated that acute respiratory diseases account for nearly 75% of the total acute morbidities globally. Therefore, various companies are offering various PCR kits that can detect the presence of pathogens that cause respiratory diseases. For instance, companies such as bioMérieux SA and altona Diagnostics GmbH provide a wide range of PCR kits that can detect acute respiratory infection in the upper or lower respiratory tract. Apart from the increasing incidence of acute and chronic respiratory diseases, other factors such as environmental and climatic conditions, air pollution, and discoveries of novel bacteria, viruses, and pathogens are likely to serve as vital growth opportunities for PCR testing for respiratory infection diagnostics in the coming future.
The PCR for respiratory infection diagnostics market is segmented real time PCR (qPCR), multiplex PCR, traditional PCR, digital PCR, reverse transcriptase PCR (RT-PCR) and others. The real time PCR held the largest share in 2021, also the same segment is anticipated to register the highest CAGR in the market during the coming years. Real Time PCR Real-time reverse transcription polymerase chain reaction (RT–PCR) is a nuclear-based approach for identifying the presence of specific genetic material in any disease, including viruses. Originally, radioactive isotope markers are used to detect specific genetic elements, but later improvement has resulted in the application of specialized markers, most often fluorescent dyes, to replace isotopic labelling.
Buy Complete Report of PCR for respiratory infection diagnostics Market Study at: https://www.theinsightpartners.com/buy/TIPRE00023326/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
Contact Person: Sameer Joshi